Silver Bullet Therapeutics, Inc.

Silver Bullet is developing OrthoFuzIon, an antimicrobial coating based on proprietary silver ionization technology designed to prevent contaminations associated with medical device implants. There is a significant clinical need to prevent bacteria from contaminating patients upon medical device implantation. The CMS “Bundled Payments for Care Improvement” (BPCI) may be a dramatic driving force for market adoption of OrthoFuzIon and Galvanis Technology. Over 10 years of development, testing, and animal trials have enabled technology perfection.